$ News

CureVac N.V. (CVAC) Shareholder/Analyst Call Prepared Remarks Transcript

Amphastar Pharmaceuticals (AMPH) Q3 Earnings and Revenues Top Estimates

BioNTech Commences Public Exchange Offer for All Outstanding Shares of CureVac N.V.

CureVac (NasdaqGM:CVAC) Valuation in Focus After Recent Share Price Movements

Kamada (KMDA) Q2 Earnings Top Estimates

CureVac N.V. (CVAC) Has Gained Over 16% In One Month. Here Is Why

CureVac Announces Voting Results of General Meeting

CureVac Soars 41% in a Month on a $1.25B Buyout Offer From BioNTech

Stocks to Watch Recap: Boeing, Oracle, GE Aerospace, GameStop

BioNTech bolsters mRNA pipeline with $1.25bn CureVac acquisition

Stocks to Watch Thursday: Boeing, Oracle, Oklo, CureVac

COVID-19 Vaccine Maker BioNTech Buys CureVac as It Aims for Cancer Treatments

BioNTech to Acquire CureVac in $1.25 Billion All-Stock Deal

BioNTech buys mRNA, courtroom rival CureVac in all-stock deal

BioNTech to Acquire CureVac in Stock Deal Valued Around $1.25 Billion

BioNTech takes over CureVac in $1.25 billion all-stock deal among COVID rivals

We Think CureVac's (NASDAQ:CVAC) Robust Earnings Are Conservative

CureVac First Quarter 2025 Earnings: Misses Expectations

Earnings Beat: CureVac N.V. (NASDAQ:CVAC) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts

CureVac Announces Financial Results for the First Quarter of 2025 and Provides Business Updates